These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15644050)

  • 1. Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.
    Qasim A; Sebastian S; Thornton O; Dobson M; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Aliment Pharmacol Ther; 2005 Jan; 21(1):91-6. PubMed ID: 15644050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of Helicobacter pylori: recent advances in treatment.
    McLoughlin RM; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2005 Aug; 19(4):421-7. PubMed ID: 16011728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy.
    Ebrahimi-Dariani N; Mirmomen S; Mansour-Ghanaei F; Noormohammadpoor P; Sotodehmanesh R; Haghpanah B; Bahrami H
    Med Sci Monit; 2003 Aug; 9(8):PI105-8. PubMed ID: 12942042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
    Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
    J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
    Gisbert JP; Olivares D; Jimenez I; Pajares JM
    Dig Liver Dis; 2006 Apr; 38(4):254-9. PubMed ID: 16309984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1469-74. PubMed ID: 17032282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadruple therapy with medications containing either rufloxacin or furazolidone as a rescue regimen in the treatment of Helicobacter pylori-infected dyspepsia patients: a randomized pilot study.
    Gu LY; Lin WW; Lu H; Chen XY; Ge ZZ; Li XB
    Helicobacter; 2011 Aug; 16(4):284-8. PubMed ID: 21762267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice.
    Van der Poorten D; Katelaris PH
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1537-42. PubMed ID: 17903237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin.
    Toracchio S; Capodicasa S; Soraja DB; Cellini L; Marzio L
    Dig Liver Dis; 2005 Jan; 37(1):33-8. PubMed ID: 15702857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
    Gisbert JP; Castro-Fernandez M; Perez-Aisa A; Cosme A; Molina-Infante J; Rodrigo L; Modolell I; Cabriada JL; Gisbert JL; Lamas E; Marcos E; Calvet X
    Aliment Pharmacol Ther; 2012 Apr; 35(8):941-7. PubMed ID: 22372560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
    Navarro-Jarabo JM; Fernández N; Sousa FL; Cabrera E; Castro M; Ramírez LM; Rivera R; Ubiña E; Vera F; Méndez I; Rivas-Ruiz F; Moreno JL; Perea-Milla E
    BMC Gastroenterol; 2007 Jul; 7():31. PubMed ID: 17651479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL]